Shufa Yang

458 total citations
6 papers, 77 citations indexed

About

Shufa Yang is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Shufa Yang has authored 6 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Shufa Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Shufa Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Shufa Yang collaborates with scholars based in China. Shufa Yang's co-authors include Xilin Du, Ruocai Xu, Dou Ke-feng, Tianqi Liu, Zhiming Wang, Xiaobin Feng, Hongzhi Zhao, Weidong Jia, Kuansheng Ma and Jun Xu and has published in prestigious journals such as The American Journal of Gastroenterology, Współczesna Onkologia and PubMed.

In The Last Decade

Shufa Yang

6 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shufa Yang China	4	56	30	19	19	14	6	77
Carmen Álvarez‐Navascués Spain	4	45 0.8×	42 1.4×	10 0.5×	15 0.8×	8 0.6×	9	71
Xuetao Shi China	6	38 0.7×	17 0.6×	23 1.2×	8 0.4×	12 0.9×	18	86
Jigjidsuren Chinburen Mongolia	5	51 0.9×	44 1.5×	13 0.7×	10 0.5×	24 1.7×	9	108
Danny Orabi United States	7	36 0.6×	31 1.0×	29 1.5×	5 0.3×	12 0.9×	10	91
Jonathan W. Fawcett Taiwan	3	64 1.1×	23 0.8×	27 1.4×	17 0.9×	7 0.5×	5	81
Liqun Wu China	6	77 1.4×	29 1.0×	55 2.9×	14 0.7×	25 1.8×	13	117
Yehia I. Abugabal United States	3	46 0.8×	26 0.9×	8 0.4×	6 0.3×	12 0.9×	12	80
Hansen Dang Vietnam	3	42 0.8×	63 2.1×	8 0.4×	10 0.5×	10 0.7×	7	85
Uta Dahmen Germany	4	39 0.7×	31 1.0×	53 2.8×	9 0.5×	15 1.1×	4	108
Yoko Yoshimaru Japan	6	41 0.7×	24 0.8×	11 0.6×	14 0.7×	6 0.4×	16	61

Countries citing papers authored by Shufa Yang

Since Specialization

Citations

This map shows the geographic impact of Shufa Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufa Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufa Yang more than expected).

Fields of papers citing papers by Shufa Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufa Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufa Yang. The network helps show where Shufa Yang may publish in the future.

Co-authorship network of co-authors of Shufa Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shufa Yang. A scholar is included among the top collaborators of Shufa Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufa Yang. Shufa Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Huang, Wukui, et al.. (2017). S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature. Współczesna Onkologia. 1(1). 16–20. 3 indexed citations

2.

Huang, Wukui, et al.. (2017). Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE.. PubMed. 21(4). 909–916. 5 indexed citations

3.

Huang, Wukui, et al.. (2017). S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma.. PubMed. 21(6). 1388–1393. 1 indexed citations

4.

Huang, Wukui, et al.. (2016). Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE. Współczesna Onkologia. 6(6). 468–474. 6 indexed citations

5.

Huang, Wukui, et al.. (2015). Jinlong capsule decreases adverse reactions after transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma ⁎. Oncology and Translational Medicine. 1(2). 87–91. 3 indexed citations

6.

Feng, Xiaobin, Ruocai Xu, Xilin Du, et al.. (2014). Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. The American Journal of Gastroenterology. 109(12). 1891–1899. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact